Literature DB >> 2358573

The impact of fluctuating relationships with the Canadian health care system on family management of otitis media with effusion.

J Wuest1, P N Stern.   

Abstract

The analysis of data from a grounded theory study of family interaction when a child has otitis media with effusion (OME) shows that these families are engaged in the process of learning to manage. Their relationship with the health care system, coupled with the effects of the disease on the child and the family lifestyle, has a powerful influence on how this process proceeds. In this paper, the authors discuss the impact of the family's relationship with the Canadian health care system on the development of management skills. Relationships with the health care system fluctuate forward and backward through entrusting, becoming disillusioned, learning the rules and negotiating, as families learn to manage the effects of the disease process on the child and the family. The family perspective of the quality and availability of health care at a time when health care systems throughout the world are under close scrutiny, adds to our understanding of consumer expectations. Some recommendations for improving current relationships between families and the health care system are made.

Entities:  

Mesh:

Year:  1990        PMID: 2358573     DOI: 10.1111/j.1365-2648.1990.tb01854.x

Source DB:  PubMed          Journal:  J Adv Nurs        ISSN: 0309-2402            Impact factor:   3.187


  2 in total

1.  Parents Need More Support: A Qualitative Study of the Experiences of Australian Parents Who Are Waiting for Surgical Intervention for Their Children With Otitis Media.

Authors:  Jacqueline H Stephens; Maree O'Keefe; Mark Schembri; Peter A Baghurst
Journal:  J Patient Exp       Date:  2019-10-22

Review 2.  Parental views on otitis media: systematic review of qualitative studies.

Authors:  Shingisai Chando; Christian Young; Jonathan C Craig; Hasantha Gunasekera; Allison Tong
Journal:  Eur J Pediatr       Date:  2016-09-10       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.